Real-world outcomes after pembrolizumab treatment for cervical cancer: Results from a university setting

Objective: To estimate survival among patients with cervical cancer treated with pembrolizumab, examine risk factors for poor outcomes, and assess toxicities in a real-world setting. Methods: This retrospective study included patients treated with pembrolizumab for advanced or recurrent cervical can...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachel L. Furuya, Katelin Boak, Mary M. Mullen, Dong Wang, L. Stewart Massad
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925001468
Tags: Add Tag
No Tags, Be the first to tag this record!